Ligne 41 : |
Ligne 41 : |
| | | |
| == Sélection de publications == | | == Sélection de publications == |
− | * https://www.ncbi.nlm.nih.gov/pubmed/25302490 Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study.<br>Bradstreet JJ, Sych N, [[Nicola Antonucci|Antonucci N]], Klunnik M, Ivankova O, Matyashchuk I, Demchuk M, [[Dario Siniscalco|Siniscalco D.]]<br>Cell Transplant. 2014; 23 Suppl 1:S105-12. | + | * https://www.ncbi.nlm.nih.gov/pubmed/25302490 Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study. Bradstreet JJ, Sych N, [[Nicola Antonucci|Antonucci N]], Klunnik M, Ivankova O, Matyashchuk I, Demchuk M, [[Dario Siniscalco|Siniscalco D.]] ''Cell Transplant.'' 2014; 23 Suppl 1:S105-12. |
− | * https://www.ncbi.nlm.nih.gov/pubmed/24772244 Mesenchymal stem cells in treating autism: Novel insights.<br>[[Dario Siniscalco|Siniscalco D]], Bradstreet JJ, Sych N, [[Nicola Antonucci|Antonucci N.]] <br>World J Stem Cells. 2014 Apr 26 | + | * https://www.ncbi.nlm.nih.gov/pubmed/24772244 Mesenchymal stem cells in treating autism: Novel insights.<br>[[Dario Siniscalco|Siniscalco D]], Bradstreet JJ, Sych N, [[Nicola Antonucci|Antonucci N.]] ''World J Stem Cells.'' 2014 Apr 26 |
− | * https://www.ncbi.nlm.nih.gov/pubmed/24222772 Perspectives on the use of stem cells for autism treatment.<br>[[Dario Siniscalco|Siniscalco D]], Bradstreet JJ, Sych N, [[Nicola Antonucci|Antonucci N.]]<br>Stem Cells Int. 2013 | + | * https://www.ncbi.nlm.nih.gov/pubmed/24222772 Perspectives on the use of stem cells for autism treatment.<br>[[Dario Siniscalco|Siniscalco D]], Bradstreet JJ, Sych N, [[Nicola Antonucci|Antonucci N.]] ''Stem Cells Int. 2013'' |
− | * https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810518/ Perspectives on the Use of Stem Cells for Autism Treatment<br>[[Dario Siniscalco]],* James Jeffrey Bradstreet, Nataliia Sych, and [[Nicola Antonucci]]<br>Stem Cells Int. Published online 2013 Oct 10 | + | * https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810518/ Perspectives on the Use of Stem Cells for Autism Treatment<br>[[Dario Siniscalco]],* James Jeffrey Bradstreet, Nataliia Sych, and [[Nicola Antonucci]] ''Stem Cells Int.'' 2013 Oct 10 |
| * http://link.springer.com/article/10.1007%2Fs10803-013-1824-9 [[Dario Siniscalco|Siniscalco, D.]]; Sapone, A.; Giordano, C.; Cirillo, A.; Magistris, L.; Rossi, F.; [[Alessio Fasano|Fasano, A.]]; Bradstreet, J. J.; Maione, S.; [[Nicola Antonucci|Antonucci, N.]] (2013). "Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders". ''Journal of Autism and Developmental Disorders'' | | * http://link.springer.com/article/10.1007%2Fs10803-013-1824-9 [[Dario Siniscalco|Siniscalco, D.]]; Sapone, A.; Giordano, C.; Cirillo, A.; Magistris, L.; Rossi, F.; [[Alessio Fasano|Fasano, A.]]; Bradstreet, J. J.; Maione, S.; [[Nicola Antonucci|Antonucci, N.]] (2013). "Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders". ''Journal of Autism and Developmental Disorders'' |
| * http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00140/full [[Dario Siniscalco|Siniscalco, D.]]; Bradstreet, J. J.; [[Nicola Antonucci|Antonucci, N.]] (2013). "Therapeutic Role of Hematopoietic Stem Cells in Autism Spectrum Disorder-Related Inflammation". ''Frontiers in Immunology'' | | * http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00140/full [[Dario Siniscalco|Siniscalco, D.]]; Bradstreet, J. J.; [[Nicola Antonucci|Antonucci, N.]] (2013). "Therapeutic Role of Hematopoietic Stem Cells in Autism Spectrum Disorder-Related Inflammation". ''Frontiers in Immunology'' |